Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Allergy. 2024 Feb;79(2):516-519. doi: 10.1111/all.15934. Epub 2023 Oct 31.
No abstract available

Keywords: EGPA; T2 inflammation; benralizumab; dupilumab; eosinophilic granulomatosis with polyangiitis; mepolizumab; monoclonal antibodies; omalizumab; reslizumab; severe asthma.

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal
  • Asthma* / diagnosis
  • Churg-Strauss Syndrome* / diagnosis
  • Granulomatosis with Polyangiitis*
  • Humans
  • Inflammation

Substances

  • Antibodies, Monoclonal